Efficacy and Safety of Xepol (Human Immunoglobulin) in Subjects With Post-Polio Syndrome (PPS)
Clinical trial NCT00160082 · COMPLETED
Trial details
- NCT number
- NCT00160082
- Sponsor
- Calliditas Therapeutics AB
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2001-01-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.